Swiss National Bank - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$546,000
-9.6%
160,6000.0%0.00%0.0%
Q2 2018$604,000
-8.1%
160,6000.0%0.00%0.0%
Q1 2018$657,000
-0.6%
160,600
+13.0%
0.00%0.0%
Q4 2017$661,000
-28.7%
142,100
+8.9%
0.00%0.0%
Q3 2017$927,000
-1.8%
130,5000.0%0.00%0.0%
Q2 2017$944,000
+17.4%
130,5000.0%0.00%0.0%
Q1 2017$804,000
+5.1%
130,5000.0%0.00%0.0%
Q4 2016$765,000
-0.9%
130,500
-10.2%
0.00%0.0%
Q3 2016$772,000
-19.8%
145,4000.0%0.00%
-50.0%
Q2 2016$963,000
+21.1%
145,400
-17.4%
0.00%
+100.0%
Q1 2016$795,000
+9.2%
176,100
+22.1%
0.00%
-50.0%
Q4 2015$728,000
+43.3%
144,2000.0%0.00%
+100.0%
Q3 2015$508,000
-59.9%
144,200
+13.6%
0.00%
-66.7%
Q2 2015$1,266,000
-9.9%
126,900
+14.9%
0.00%
-25.0%
Q1 2015$1,405,000
+0.1%
110,400
+11.3%
0.00%
-20.0%
Q4 2014$1,404,000
+5.2%
99,200
+2.3%
0.01%0.0%
Q3 2014$1,334,000
-10.6%
97,0000.0%0.01%
-16.7%
Q2 2014$1,492,000
-9.7%
97,0000.0%0.01%0.0%
Q1 2014$1,653,000
+82.7%
97,000
+38.8%
0.01%
+50.0%
Q4 2013$905,000
+28.2%
69,9000.0%0.00%
+33.3%
Q3 2013$706,000
+28.1%
69,900
-5.3%
0.00%
+50.0%
Q2 2013$551,00073,8000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Finepoint Capital LP 1,605,800$16,026,0004.65%
Baupost Group 25,791,678$257,401,0004.29%
1492 Capital Management LLC 264,297$2,638,0001.67%
Cormorant Asset Management, LP 826,000$8,243,0001.10%
FALCON POINT CAPITAL, LLC 251,137$2,506,0000.85%
OAK RIDGE INVESTMENTS LLC 3,291,711$32,851,0000.70%
Knoll Capital Management, LLC 200,000$1,996,0000.64%
Rhenman & Partners Asset Management AB 534,000$5,329,0000.64%
Old West Investment Management, LLC 79,667$795,0000.55%
THREE BAYS CAPITAL LP 1,284,000$12,814,0000.53%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders